Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading

AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
City & Markets

Galapagos NV Announces Gamgertamig Preliminary Phase 1b Data and Poster Presentation at 2026 ASH Meeting

Trade Hub UK regulation desk (2026-11-04): Galapagos NV announced the acceptance of a poster presentation at the 2026 American Society of Hematology Annual Meeting, scheduled for December 12-15,… Primary source: original at Nasdaq (nasdaq.com).

Galapagos NV Announces Gamgertamig Preliminary Phase 1b Data and Poster Presentation at 2026 ASH Meeting

Galapagos NV announced the acceptance of a poster presentation at the 2026 American Society of Hematology Annual Meeting, scheduled for December 12-15, featuring preliminary data for gamgertamig in relapsed/refractory autoimmune cytopenias. Gamgertamig is an investigational BCMAx

Read at source